Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares stood at 1.4 million during the latest session, with the company’s beta value hitting 1.10. At the last check
In the last trading session, 1.87 million Agile Therapeutics Inc. (NASDAQ:AGRX) shares changed hands as the company’s beta touched 1.10. With the company’s per share
Agile Therapeutics Inc. (NASDAQ:AGRX) has a beta value of 1.04 and has seen 1.03 million shares traded in the last trading session. The company, currently
During the last session, Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares were 0.61 million, with the beta value of the company hitting 1.03. The 52-week high
In the latest trading session, 1.02 million Agile Therapeutics Inc. (NASDAQ:AGRX) shares changed hands as the company’s beta touched 0.99. With the company’s most recent
In last trading session, Agile Therapeutics Inc. (NASDAQ:AGRX) saw 2.33 million shares changing hands with its beta currently measuring 1.13. Company’s recent per share price
Agile Therapeutics Inc. (NASDAQ:AGRX) has a beta value of 1.13 and has seen 1.66 million shares traded in the last trading session. The company, currently
Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares stood at 0.28 million during the latest session, with the company’s beta value hitting 1.15. At the last check